Argentina issues requirements for diabetes Type 2 clinical research
This article was originally published in SRA
Executive Summary
Argentina’s National Medicines, Food and Medical Technology Administration, ANMAT, has established new requirements – in the form of a guidelines document – for clinical research of Type 2 diabetes treatments, as well as protocol evaluation criteria for such research1,2.